Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Novel Naproxen Sodium vs Nalgesin in Healthy Volunteers
NCT03697889Phase 1Completed
- Sponsor
- McNeil Laboratories
- Start
- Dec 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Aprol in pain and inflammation (2 arms), sponsored by McNeil Laboratories. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Plasma Concentration-Time Curve to Last Measurable Concentration. Started Dec 2018; status: completed.
02
Drugs
Aprol
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT03697889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03697889.